DrRonald Castellano

Supramolecular Chain-Growth and Chain-Transfer using Heterocomplementary Paracyclophanes

Biomarker-directed repurposing of Omveloxolone for treatment of colon and pancreatic cancers

Isoform-Selective Disulfide Isomerase Inhibitors for Overcoming Drug Resistance

Processing and Characterization of High-Performance Polymeric Materials

HER1-3 and Death Receptor protein folding as therapeutic vulnerabilities

Reducing racial disparity in breast cancer survival with a novel synthetic-lethal strategy

Optimizing novel small molecule activators of Death Receptor 5 for breast cancer therapy

Programming supramolecular polymer structure and function using covalently-fixed monomers

Novel Breast Cancer Therapeutics Targeting a Unique Subset of Disulfide Isomerases

Toward IND-Enabling Studies for Novel Cancer Therapeutics that Inhibit the Disulfide Isomerases ERp44, PDIA1, and AGR2

Regulation of Death Receptor 5 folding and apoptotic signaling by AGR2

Tranexamic Class Antagonists (TXCAs)

Incorporating Tailored Hydrogen Bonding Interactions in Organic Optoelectronic Thin Films - Pursuing Universality of Form and Function

Dual mechanisms of DDA antitumor activity: Induction of tumor cell apoptosis and vascular disruption

A new approach for eradicating metastatic, drug-resistant breast cancers

MRI: Acquisition of an X-Ray Diffractometer for Next Generation Functional Molecules and Materials

Synthetic lethal strategy for killing EGFR+/HER2+ cancers

PARACYCLOPHANE SELF-ASSEMBLY PROMOTED BY TRANSANNULARHYDROGEN BONDING

Toward Mesoscale Order in Multicomponent Organic Thin Films via Hydrogen Bond Directed Supramolecular Topology

Novel Agents that simultaneously Downregulate Her2, ECFR, and Her3